Inventor
ROEMER MICHAEL
DE57 patents
⚠️ This page may combine multiple inventors who share the name “ROEMER MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
27 patentsUS4639328AJan 27, 1987
Thienothiophene derivatives
MERCK PATENT GMBH77 citations96
US4551264ANov 5, 1985
Polyhalogenoaromatic compounds for liquid crystal compositions
MERCK PATENT GMBH83 citations96
US4510069AApr 9, 1985
Cyclohexane derivatives
MERCK PATENT GMBH84 citations96
US4400293AAug 23, 1983
Liquid crystalline cyclohexylphenyl derivatives
MERCK PATENT GMBH76 citations96
US4606845AAug 19, 1986
Bicyclohexylethanes
MERCK PATENT GMBH41 citations93
US4490305ADec 25, 1984
Liquid-crystalline halogen compounds, process for their preparation, dielectrics containing these, and electro-optical display element
MERCK PATENT GMBH30 citations93
US4419264ADec 6, 1983
Fluorine-containing 4,4'-bis-(cyclohexyl)-biphenyl derivatives, and dielectrics and electro-optical display elements containing them
MERCK PATENT GMBH28 citations93
US4386007AMay 31, 1983
Liquid crystalline naphthalene derivatives
MERCK PATENT GMBH35 citations93
US4776973AOct 11, 1988
Pyrimidine derivatives
MERCK PATENT GMBH34 citations92
US4730904AMar 15, 1988
Organosilicon compounds
MERCK PATENT GMBH35 citations92
US4331552AMay 25, 1982
Liquid crystalline, partially hydrogenated oligo-1,4-phenylenes and dielectrics and electro-optical display elements containing them
MERCK PATENT GMBH43 citations92
US4699636AOct 13, 1987
Process for outgassing liquid-crystalline materials
MERCK PATENT GMBH33 citations91
US4724097AFeb 9, 1988
Bicyclohexylethanes
MERCK PATENT GMBH27 citations90
US5308538AMay 3, 1994
Supertwist liquid-crystal display
MERCK PATENT GMBH24 citations89
US5108652AApr 28, 1992
Cyclohexane derivatives
MERCK PATENT GMBH20 citations82
US4622164ANov 11, 1986
Bicyclohexyls
MERCK PATENT GMBH17 citations82
US4620938ANov 4, 1986
Hydroterphenyls
MERCK PATENT GMBH25 citations82
US4505837AMar 19, 1985
Liquid crystalline phenylcyclohexene derivatives
MERCK PATENT GMBH26 citations82
US4986931AJan 22, 1991
Cyclohexane derivatives
MERCK PATENT GMBH7 citations74
US4868341ASep 19, 1989
Bicyclohexyls
MERCK PATENT GMBH8 citations74
US4812258AMar 14, 1989
Fluorine-containing pyrimidine derivatives
MERCK PATENT GMBH15 citations74
US4505838AMar 19, 1985
Halogenobiphenyl derivatives
MERCK PATENT GMBH12 citations74
US4473487ASep 25, 1984
4-Fluorobiphenyl derivatives, their preparation, and dielectrics and electro-optical display element containing them
MERCK PATENT GMBH14 citations74
US4740624AApr 26, 1988
Process for the preparation of ketones
MERCK PATENT GMBH14 citations73
US5023379AJun 11, 1991
Process for the preparation of hydroxyamines
MERCK PATENT GMBH16 citations71
US4544771AOct 1, 1985
Halogenobiphenyl derivatives
MERCK PATENT GMBH3 citations63
US4354976AOct 19, 1982
Process for the preparation of azidobenzal compounds
MERCK PATENT GMBH2 citations63
IMMATICS BIOTECHNOLOGIES GMBH
17 patentsUS11732021B2Aug 22, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11655281B2May 23, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11655280B2May 23, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11603397B2Mar 14, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US12318407B2Jun 3, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12290530B2May 6, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12285443B2Apr 29, 2025
Peptides displayed by HLA for use immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12274716B2Apr 15, 2025
Peptides displayed by HLA for use immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12257269B2Mar 25, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12246039B2Mar 11, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12227556B2Feb 18, 2025
Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12202878B2Jan 21, 2025
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12195516B2Jan 14, 2025
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12084486B2Sep 10, 2024
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11957716B2Apr 16, 2024
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11779605B2Oct 10, 2023
Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11433099B2Sep 6, 2022
Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
SECR DEFENCE BRIT
2 patentsSCHERING AG
2 patentsHOECHST AG
1 patentMANNESMANN VDO AG
1 patentShowing the top 50 of 57 patents by PatentIndex Score.